An interdomain RNA binding site on the hepadnaviral polymerase that is essential for reverse transcription

Virology

Volumn 390, Issue 1, 2009, Pages 130-138

  Badtke, Matthew P ^a   Khan, Irfan ^a   Cao, Feng ^a   Hu, Jianming ^c   Tavis, John E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Saint Louis University   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Hepadnavirus; Hepatitis B virus; Reverse transcriptase; Reverse transcription; RNA binding

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA BINDING MOTIF; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; EPITOPE MAPPING; HEPADNAVIRUS; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HEPADNAVIRIDAE; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTION; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; SEQUENCE HOMOLOGY, AMINO ACID;

DUCK HEPATITIS B VIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS;

EID: 67649479264     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.04.023     Document Type: Article

References (50)

1. Badtke M.P., Cao F., and Tavis J.E. Combining genetic and biochemical approaches to identify functional molecular contact points. Biol. Proced. Online 8 (2006) 77-86
2. Bartenschlager R., Junker-Niepmann M., and Schaller H. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64 (1990) 5324-5332
3. Bartholomeusz A., and Locarnini S.A. Antiviral drug resistance: clinical consequences and molecular aspects. Semin. Liver Dis. 26 (2006) 162-170
4. Bartholomeusz A., Tehan B.G., and Chalmers D.K. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir. Ther. 9 (2004) 149-160
5. Beck J., and Nassal M. Sequence- and structure-specific determinants in the interaction between the RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J. Virol. 71 (1997) 4971-4980
6. Beck J., and Nassal M. Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol. Cell Biol. 18 (1998) 6265-6272
7. Beck J., and Nassal M. Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J. Biol. Chem. 278 (2003) 36128-36138
8. Cao F., Badtke M.P., Metzger L.M., Yao E., Adeyemo B., Gong Y.H., and Tavis J.E. Identification of an essential molecular contact point on the duck hepatitis B virus reverse transcriptase. J. Virol. 79 (2005) 10164-10170
9. Chang L.J., Hirsch R.C., Ganem D., and Varmus H.E. Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J. Virol. 64 (1990) 5553-5558
10. Das K., Xiong X., Yang H., Westland C.E., Gibbs C.S., Sarafianos S.G., and Arnold E. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J. Virol. 75 (2001) 4771-4779
11. Delarue M., Poch O., Tordo N., Moras D., and Argos P. An attempt to unify the structure of polymerases. Protein Eng. 3 (1990) 461-467
12. Ferrari E., Wright-Minogue J., Fang J.W.S., Baroudy B.M., Lau J.Y.N., and Hong Z. Characterization of soluble hepatitis C virus RNA dependent RNA polymerase expressed in Escherichia coli. J. Virol. 73 (1999) 1649-1654
13. Ghany M., and Liang T.J. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132 (2007) 1574-1585
14. Guo H., Mason W.S., Aldrich C.E., Saputelli J.R., Miller D.S., Jilbert A.R., and Newbold J.E. Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J. Virol. 79 (2005) 2729-2742
15. Hirsch R.C., Lavine J.E., Chang L.J., Varmus H.E., and Ganem D. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature (London) 344 (1990) 552-555
16. Hu J., and Anselmo D. In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by HSP90. J. Virol. 74 (2000) 11447-11455
17. Hu J., and Boyer M. Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro. J. Virol. 80 (2006) 2141-2150
18. Hu J., and Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1060-1064
19. Hu J., Toft D.O., and Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16 (1997) 59-68
20. Hu J., Toft D., Anselmo D., and Wang X. In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J. Virol. 76 (2002) 269-279
21. Hu J., Flores D., Toft D., Wang X., and Nguyen D. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 78 (2004) 13122-13131
22. Junker-Niepmann M., Bartenschlager R., and Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 9 (1990) 3389-3396
23. Kolodziej P.A., and Young R.A. Epitope Tagging and Protein Surveillance. Methods Enzymol. 194 (1991) 508-519
24. Lanford R.E., Notvall L., Lee H., and Beams B. Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71 (1997) 2996-3004
25. Lanford R.E., Chavez D., Brasky K.M., Burns III R.B., and Rico-Hesse R. Isolation of a hepadnavirus from the woolly monkey, a New World primate. PNAS 95 (1998) 5757-5761
26. Lanford R.E., Kim Y.H., Lee H., Notvall L., and Beames B. Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction. J. Virol. 73 (1999) 1885-1893
27. Langley D.R., Walsh A.W., Baldick C.J., Eggers B.J., Rose R.E., Levine S.M., Kapur A.J., Colonno R.J., and Tenney D.J. Inhibition of hepatitis B virus polymerase by entecavir. J. Virol. 81 (2007) 3992-4001
28. Lin L., and Hu J. Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds. J. Virol. 82 (2008) 2305-2312
29. Lin L., Wan F., and Hu J. Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions. J. Virol. 82 (2008) 5703-5714
30. Poch O., Sauvaget I., Delarue M., and Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8 (1989) 3867-3874
31. Pollack J.R., and Ganem D. Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J. Virol. 68 (1994) 5579-5587
32. Potenza N., Salvatore V., Raimondo D., Falanga D., Nobile V., Peterson D.L., and Russo A. Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expr. Purif. 55 (2007) 93-99
33. Radziwill G., Zentgraf H., Schaller H., and Bosch V. The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template. Virology 163 (1988) 123-132
34. Radziwill G., Tucker W., and Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64 (1990) 613-620
35. Schoedel F., Sprengel R., Weimer T., Fernholz D., Schneider R., and Will H. Animal hepatitis B viruses. Adv. Viral Oncol. 8 (1989) 73-102
36. Seeger C., Leber E.H., Wiens L.K., and Hu J. Mutagenesis of a hepatitis B virus reverse transcriptase yields temperature-sensitive virus. Virology 222 (1996) 430-439
37. Seeger C., Zoulim F., and Mason W.S. Hepadnaviruses. In: Knipe D.M., Howley P., Griffin D.E., Lamb R.A., Martin A., Roizman B., and Straus S.E. (Eds). Fields Virology (2007), Lippincott Williams and Wilkins, Philadelphia 2977-3029
38. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28 (2006) 112-125
39. Sprengel R., Kuhn C., Will H., and Schaller H. Comparative sequence analysis of duck and human hepatitis B virus genomes. J. Med. Virol. 15 (1985) 323-333
40. Stahl M., Beck J., and Nassal M. Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding. J. Virol. 81 (2007) 13354-13364
41. Summers J., and Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29 (1982) 403-415
42. Tavis J.E., and Ganem D. Evidence for the activation of the hepatitis B virus polymerase by binding of its RNA template. J. Virol. 70 (1996) 5741-5750
43. Tavis J.E., Perri S., and Ganem D. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J. Virol. 68 (1994) 3536-3543
44. Tavis J.E., Massey B., and Gong Y. The duck hepatitis B virus polymerase is activated by its RNA packaging signal, Epsilon. J. Virol. 72 (1998) 5789-5796
45. Wang G.H., and Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67 (1993) 6507-6512
46. Wang G.H., Zoulim F., Leber E.H., Kitson J., and Seeger C. Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J. Virol. 68 (1994) 8437-8442
47. Wang X., Qian X., Guo H.C., and Hu J. Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase. J. Virol. 77 (2003) 4471-4480
48. Weber M., Bronsema V., Bartos H., Bosserhoff A., Bartenschlager R., and Schaller H. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 68 (1994) 2994-2999
49. Xiong Y., and Eickbush T.H. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9 (1990) 3353-3362
50. Zoulim F., and Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68 (1994) 6-13